Evidence map›Paper›PMID 26676251›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Phenylalanine transfer across the isolated perfused human placenta: an experimental and modeling investigation.

E M Lofthouse, S Perazzolo, S Brooks, I P Crocker, J D Glazier, E D Johnstone, N Panitchob, C P Sibley, K L Widdows, B G Sengers and 1 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

E M LofthouseFaculty of Medicine, University of Southampton, Southampton, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
S PerazzoloBioengineering Science Research Group, Faculty of Engineering and the Environment, University of Southampton, Southampton, United Kingdom;
S BrooksFaculty of Medicine, University of Southampton, Southampton, United Kingdom;
I P CrockerMaternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, and St. Mary's Hospital and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; and.
J D GlazierMaternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, and St. Mary's Hospital and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; and.
E D JohnstoneMaternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, and St. Mary's Hospital and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; and.
N PanitchobBioengineering Science Research Group, Faculty of Engineering and the Environment, University of Southampton, Southampton, United Kingdom;
C P SibleyMaternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, and St. Mary's Hospital and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; and.
K L WiddowsMaternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, and St. Mary's Hospital and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; and.
B G SengersBioengineering Science Research Group, Faculty of Engineering and the Environment, University of Southampton, Southampton, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
R M LewisFaculty of Medicine, University of Southampton, Southampton, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom Rohan.Lewis@soton.ac.uk.ORCID 0000-0003-4044-9104
University of Southampton · GBManchester Academic Health Science Centre · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I011250/1Biotechnology and Biological Sciences Research Council BB/I011315/1
6 · The paper itself

Abstract

Membrane transporters are considered essential for placental amino acid transfer, but the contribution of other factors, such as blood flow and metabolism, is poorly defined. In this study we combine experimental and modeling approaches to understand the determinants of [(14)C]phenylalanine transfer across the isolated perfused human placenta. Transfer of [(14)C]phenylalanine across the isolated perfused human placenta was determined at different maternal and fetal flow rates. Maternal flow rate was set at 10, 14, and 18 ml/min for 1 h each. At each maternal flow rate, fetal flow rates were set at 3, 6, and 9 ml/min for 20 min each. Appearance of [(14)C]phenylalanine was measured in the maternal and fetal venous exudates. Computational modeling of phenylalanine transfer was undertaken to allow comparison of the experimental data with predicted phenylalanine uptake and transfer under different initial assumptions. Placental uptake (mol/min) of [(14)C]phenylalanine increased with maternal, but not fetal, flow. Delivery (mol/min) of [(14)C]phenylalanine to the fetal circulation was not associated with fetal or maternal flow. The absence of a relationship between placental phenylalanine uptake and net flux of phenylalanine to the fetal circulation suggests that factors other than flow or transporter-mediated uptake are important determinants of phenylalanine transfer. These observations could be explained by tight regulation of free amino acid levels within the placenta or properties of the facilitated transporters mediating phenylalanine transport. We suggest that amino acid metabolism, primarily incorporation into protein, is controlling free amino acid levels and, thus, placental transfer.

Indexed as

Models, BiologicalBiological TransportCarbon RadioisotopesCreatinineFemaleHumansMaternal-Fetal ExchangePerfusionPhenylalaninePlacentaPregnancyCarbon RadioisotopesCreatininePhenylalanineamino acid transferblood flowexchangerfacilitated transportmetabolism

Identifiers

PMID26676251
PMCPMC5000773
OpenAlexW2209867392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.